DxCodebookFY2027 · Oct 1, 2026 – Sep 30, 2027

Category · FY2027

P04 Newborn affected by noxious substances transmitted via placenta or breast milk

  • Header · not billable

P04 is not billable. The category heads 22 billable codes in FY2027, grouped under 9 subdivisions.

Index → code

  • Crack baby → P04.41
  • Tobacco (nicotine)maternal use, affecting newborn → P04.2
  • Noxioussubstances transmitted through placenta or breast milk → P04.9

Where it sits

  1. Chapter 16 Certain conditions originating in the perinatal period (P00-P96)
  2. P00-P04 Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery (P00-P04)
  3. P04 Newborn affected by noxious substances transmitted via placenta or breast milk
Billable codes
22
Subdivisions
9
CC / MCC codes
0 / 0
HCC V28 codes
22
New FY2027
0
Index entries
45

Codes in P04

  1. P04.0
    Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
    Billable137
    Inclusion terms 1, Excludes2 1

    Inclusion terms

    • Newborn affected by reactions and intoxications from maternal opiates and tranquilizers administered for procedures during pregnancy or labor and delivery

    Excludes2

    • newborn affected by other maternal medication (P04.1-) P04.1
  2. P04.1
    Newborn affected by other maternal medication
    Header
    Excludes1 2, Excludes2 2, Code first 2

    Excludes1

    • dysmorphism due to warfarin (Q86.2) Q86.2
    • fetal hydantoin syndrome (Q86.1) Q86.1

    Excludes2

    • maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0) P04.0
    • maternal use of drugs of addiction (P04.4-) P04.4

    Code first

    • , if applicable, withdrawal symptoms from maternal use of drugs of addiction (P96.1) P96.1
    • withdrawal symptoms from therapeutic use of drugs in newborn (P96.2) P96.2
  3. P04.11
    Newborn affected by maternal antineoplastic chemotherapy
    Billable137
  4. P04.12
    Newborn affected by maternal cytotoxic drugs
    Billable137
  5. P04.13
    Newborn affected by maternal use of anticonvulsants
    Billable137
  6. P04.14
    Newborn affected by maternal use of opiates
    Billable137
  7. P04.15
    Newborn affected by maternal use of antidepressants
    Billable137
  8. P04.16
    Newborn affected by maternal use of amphetamines
    Billable137
  9. P04.17
    Newborn affected by maternal use of sedative-hypnotics
    Billable137
  10. P04.1A
    Newborn affected by maternal use of anxiolytics
    Billable137
  11. P04.18
    Newborn affected by other maternal medication
    Billable137
  12. P04.19
    Newborn affected by maternal use of unspecified medication
    Billable137
  13. P04.2
    Newborn affected by maternal use of tobacco
    Billable137
    Inclusion terms 1, Excludes2 1

    Inclusion terms

    • Newborn affected by exposure in utero to tobacco smoke

    Excludes2

    • newborn exposure to environmental tobacco smoke (P96.81) P96.81
  14. P04.3
    Newborn affected by maternal use of alcohol
    Billable137
    Excludes1 1

    Excludes1

    • fetal alcohol syndrome (Q86.0) Q86.0
  15. P04.4
    Newborn affected by maternal use of drugs of addiction
    Header
  16. P04.40
    Newborn affected by maternal use of unspecified drugs of addiction
    Billable137
  17. P04.41
    Newborn affected by maternal use of cocaine
    Billable137
  18. P04.42
    Newborn affected by maternal use of hallucinogens
    Billable137
    Excludes2 1

    Excludes2

    • newborn affected by other maternal medication (P04.1-) P04.1
  19. P04.49
    Newborn affected by maternal use of other drugs of addiction
    Billable137
    Excludes2 2

    Excludes2

    • newborn affected by maternal anesthesia and analgesia (P04.0) P04.0
    • withdrawal symptoms from maternal use of drugs of addiction (P96.1) P96.1
  20. P04.5
    Newborn affected by maternal use of nutritional chemical substances
    Billable137
  21. P04.6
    Newborn affected by maternal exposure to environmental chemical substances
    Billable137
  22. P04.8
    Newborn affected by other maternal noxious substances
    Header
  23. P04.81
    Newborn affected by maternal use of cannabis
    Billable137
  24. P04.89
    Newborn affected by other maternal noxious substances
    Billable137
  25. P04.9
    Newborn affected by maternal noxious substance, unspecified
    Billable137

Sources of each column.

Instructions

At P04

Includes

  • nonteratogenic effects of substances transmitted via placenta

Excludes2

  • congenital malformations (Q00-Q99) Q00 Q99
  • encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-) Z05
  • neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4) P58.4
  • newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-) Z77

Code first

  • any current condition in newborn, if applicable

Notes that also apply

Block P00-P04 instructions (Notes 1): printed on the block page.

Chapter 16 instructions (Notes 1, Includes 1, Excludes2 5): printed on the chapter 16 page.

Index entries

  • Crack baby → P04.41
  • Tobacco (nicotine)maternal use, affecting newborn → P04.2
  • Noxioussubstances transmitted through placenta or breast milk → P04.9
  • Newborn (infant) (liveborn) (singleton)affected bychemotherapy agents → P04.11
  • Absorptiondrug NECthrough placenta (newborn) → P04.19
  • Newborn (infant) (liveborn) (singleton)affected bymedication (legal) (maternal use) (prescribed) → P04.19
  • Newborn (infant) (liveborn) (singleton)affected bytobacco → P04.2
  • Newborn (infant) (liveborn) (singleton)affected bydrugs of addiction → P04.40
  • Newborn (infant) (liveborn) (singleton)affected bycocaine (crack) → P04.41
  • Newborn (infant) (liveborn) (singleton)affected bymethamphetamine(s) → P04.49
  • Newborn (infant) (liveborn) (singleton)affected bynutritional supplements → P04.5
  • Newborn (infant) (liveborn) (singleton)affected byenvironmental chemicals → P04.6
  • Absorptionchemicalthrough placenta (newborn) → P04.9
  • Newborn (infant) (liveborn) (singleton)affected bynoxious substances transmitted via placenta or breast milk → P04.9
  • Absorptionchemicalthrough placenta (newborn)obstetric anesthetic or analgesic drug → P04.0
  • Absorptiondrug NECthrough placenta (newborn)obstetric anesthetic or analgesic drug → P04.0
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)analgesia (maternal) → P04.0
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)anesthesia (maternal) → P04.0
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)tranquilizers administered for procedures during pregnancy or labor and delivery → P04.0
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)antineoplastic chemotherapy → P04.11
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)cytotoxic drugs → P04.12
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)anticonvulsants → P04.13
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)opiates → P04.14
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)antidepressants → P04.15
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)amphetamines → P04.16
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)sedative-hypnotics → P04.17
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)anxiolytics → P04.1A
  • Absorptiondrug NECmedicinalthrough placenta (newborn) → P04.19
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)medication → P04.19
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)alcohol → P04.3
  • Absorptiondrug NECaddictivethrough placenta (newborn) → P04.40
  • Newborn (infant) (liveborn) (singleton)affected bydrugs of addictioncocaine → P04.41
  • Newborn (infant) (liveborn) (singleton)affected bydrugs of addictionhallucinogens → P04.42
  • Newborn (infant) (liveborn) (singleton)affected bydrugs of addictionspecified drug NEC → P04.49
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)drugs (addictive) (illegal) NEC → P04.49
  • Absorptionchemicalthrough placenta (newborn)nutritional substance → P04.5
  • Absorptionchemicalthrough placenta (newborn)environmental substance → P04.6
  • Newborn (infant) (liveborn) (singleton)affected bymaternal (complication of) (use of)cannabis → P04.81
  • Newborn (infant) (liveborn) (singleton)affected bynoxious substances transmitted via placenta or breast milkcannabis → P04.81
  • Newborn (infant) (liveborn) (singleton)affected bynoxious substances transmitted via placenta or breast milkspecified NEC → P04.89

5 more, longer entries are not listed; the search box finds them by word.

NCHS Alphabetic Index. Index first, then the Tabular List.

Hierarchy